Anbio Biotechnology (NNNN) Short-term Investments (2023 - 2025)
Anbio Biotechnology (NNNN) posted Short-term Investments of $4.1 million for Q4 2025, down 48.83% on a QoQ basis from $8.1 million in Q2 2025.
Analysis
Anbio Biotechnology (NNNN) Short-term Investments (2023 - 2025) Analysis & Trends
Anbio Biotechnology has reported Short-term Investments for 2 years, with the latest figure at $4.1 million in Q4 2025.
- On a quarterly basis, Short-term Investments changed N/A year-over-year to $4.1 million in Q4 2025; TTM through Dec 2025 was $4.1 million, a N/A change from a year earlier, with the FY2025 full-year figure at $4.1 million, changed N/A from the prior year.
- Short-term Investments was $4.1 million for Q4 2025 at Anbio Biotechnology, down from $8.1 million in the prior quarter.
- The five-year high for Short-term Investments was $8.1 million in Q2 2025, with the low at $3263.0 in Q4 2023.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | GE HealthCare Technologies | 28.97 Bn | 27.09 Bn | 2.18 Bn |
| 2 | Lantheus Holdings | 6.56 Bn | 5.97 Bn | 241.86 Mn |
| 3 | Heartflow | 4.40 Bn | 4.03 Bn | 53.19 Mn |
| 4 | Neogen | 2.83 Bn | 2.64 Bn | 107.80 Mn |
| 5 | Butterfly Network | 1.88 Bn | 1.75 Bn | 23.29 Mn |
| 6 | Ceribell | 931.50 Mn | 802.24 Mn | 25.94 Mn |
| 7 | Varex Imaging | 779.32 Mn | 694.02 Mn | 76.70 Mn |
| 8 | Anbio Biotechnology | 755.43 Mn | 743.53 Mn | - |
| 9 | QuidelOrtho | 725.35 Mn | 601.95 Mn | - |
| 10 | Prenetics Global | 339.92 Mn | 280.78 Mn | 30.20 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | 4.13 Mn |
| Jun 30, 2025 | 8.08 Mn |
| Dec 31, 2023 | 3,263.00 |